LRCX insider trades: option exercise 6,010; sales at $157.46–$157.48

Q: What insider transactions did LRCX report on 10/27/2025?

The Chief Legal Officer sold 3,000 shares at $157.48 , exercised options for 6,010 shares at $77.039 , and sold 6,010 shares at $157.46 .

Q: How many LRCX shares does the reporting officer hold after the transactions?

Beneficial ownership is 56,786.455 shares directly, including shares subject to unvested RSUs.

Q: What options remain for the LRCX officer after these trades?

The filing lists 12,020 employee stock options remaining, expiring on 08/05/2031 .

Q: When did the exercised LRCX options vest?

They became exercisable in three equal installments on 03/01/2025 , 03/01/2026 , and 03/01/2027 .

Q: What is the exercise price for the LRCX options exercised?

The exercise price reported is $77.039 per share.

Filing Impact

(Very High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Lam Research (LRCX) reported insider transactions by its Chief Legal Officer. On 10/27/2025, the officer sold 3,000 shares of common stock at $157.48, exercised employee stock options for 6,010 shares at an exercise price of $77.039, and sold 6,010 shares at $157.46.

Following these transactions, the officer beneficially owned 56,786.455 shares directly, which includes shares subject to unvested restricted stock units. The filing shows 12,020 derivative securities (employee stock options) remaining, expiring on 08/05/2031. The options referenced became exercisable in three equal installments on 03/01/2025, 03/01/2026, and 03/01/2027.

Insider Trade Summary

Net Seller: 9,010 shares ($1,418,775)

Net Sell 4 txns

Insider Harter Ava

Role Chief Legal Officer

Sold 9,010 shs ($1.42M)

Type	Security	Shares	Price	Value
Exercise	Employee Stock Option (Right to Buy)	6,010	$0.00	--
Sale	Common Stock	3,000	$157.48	$472K
Exercise	Common Stock	6,010	$77.039	$463K
Sale	Common Stock	6,010	$157.46	$946K

Holdings After Transaction: Employee Stock Option (Right to Buy) — 12,020 shares (Direct); Common Stock — 56,786.455 shares (Direct)

Footnotes (1)

The amount reported includes shares subject to unvested restricted stock units. The stock options will become exercisable in three equal installments on 03/01/2025, 03/01/2026, and 03/01/2027.

Form 4 Insider Transactions: What Each Field Means →

10/28/2025 - 11:53 AM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Harter Ava

(Last)

(First)

(Middle)

4650 CUSHING PKWY

(Street)

FREMONT

94538

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
LAM RESEARCH CORP [ LRCX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Legal Officer

3. Date of Earliest Transaction (Month/Day/Year)
10/27/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	10/27/2025		S		3,000	D	$157.48	56,786.455⁽¹⁾	D
Common Stock	10/27/2025		M		6,010	A	$77.039	62,796.455⁽¹⁾	D
Common Stock	10/27/2025		S		6,010	D	$157.46	56,786.455⁽¹⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Employee Stock Option (Right to Buy)	$77.039	10/27/2025		M			6,010	⁽²⁾	08/05/2031	Common Stock	6,010	$0	12,020	D

Explanation of Responses:

1. The amount reported includes shares subject to unvested restricted stock units.

2. The stock options will become exercisable in three equal installments on 03/01/2025, 03/01/2026, and 03/01/2027.

Remarks:

	Marta Woods by Power of Attorney	10/28/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did LRCX report on 10/27/2025?

The Chief Legal Officer sold 3,000 shares at $157.48, exercised options for 6,010 shares at $77.039, and sold 6,010 shares at $157.46.

How many LRCX shares does the reporting officer hold after the transactions?

Beneficial ownership is 56,786.455 shares directly, including shares subject to unvested RSUs.

What options remain for the LRCX officer after these trades?

The filing lists 12,020 employee stock options remaining, expiring on 08/05/2031.

When did the exercised LRCX options vest?

They became exercisable in three equal installments on 03/01/2025, 03/01/2026, and 03/01/2027.

What is the exercise price for the LRCX options exercised?

The exercise price reported is $77.039 per share.

Was the LRCX trading under a Rule 10b5-1 plan?

The excerpt includes the 10b5-1 checkbox language; a selection is not indicated in the provided text.